3M Company, US88579Y1010

3M builds on spin-off strategy, shares tracked against industrial peers

28.06.2026 - 13:30:35 | ad-hoc-news.de

3M Company continues to reshape its portfolio after the Solventum healthcare spin-off, with investors tracking how the reshaped group compares to industrial peers like Honeywell and GE Aerospace. Analysts highlight litigation, margins and balance sheet as key watchpoints.

3M Company, US88579Y1010
3M Company, US88579Y1010

By Stefan Krueger, Long-Term & Business Model desk. Reviewed prior to publication on 2026-06-28, 13:30.

3M Company (US88579Y1010) remains in focus for long-term investors after completing the spin-off of its healthcare business Solventum earlier in 2024. The reshaped group is now more comparable to diversified industrial names such as Honeywell and GE Aerospace listed on the NYSE.

What Reuters and filings show

3M finalized the tax-free spin-off of Solventum on 1 April 2024, distributing one Solventum share for every four 3M shares, according to the company’s Form 10 registration and related SEC filings. The company’s own release on the Solventum completion outlines the transaction structure and the expected strategic focus after the separation.

In parallel with the portfolio reshaping, 3M reached a series of major legal settlements in 2023 and 2024 addressing PFAS-related claims and U.S. military earplug litigation, which removed significant headline risk but left a sizable financial burden. Reuters has previously detailed the PFAS water pollution settlement framework, which foresees multi-year payments and ongoing remediation commitments.

How analysts view the new 3M

Following the spin-off and legal settlements, several research houses updated their views on 3M, focusing on deleveraging, margin improvement and litigation overhang. Market data compilations show a mixed analyst stance, with a spread of ratings from Sell to Buy and an average "Hold"-type view on the NYSE-listed stock. MarketScreener’s analyst consensus page for 3M highlights that many houses expect only modest earnings growth over the next two years.

Litigation remains a core valuation factor for analysts, who continue to monitor the implementation of the earplug and PFAS settlements and any residual exposures. At the same time, they point to potential upside if 3M executes cost reductions and portfolio pruning consistently, in line with moves already seen across U.S. industrial peers such as Honeywell, GE Aerospace and Emerson.

Go deeper

All news and analysis on the 3M Company shares

Follow recent corporate announcements, analyst commentary and litigation updates that continue to shape expectations for 3M Company on the NYSE.

What the company sells today

Post spin-off, 3M focuses on safety and industrial products, transportation and electronics, and consumer offerings such as Post-it sticky notes, Scotch tapes and home-improvement items. These lines give the group broad exposure to global manufacturing, construction, automotive and retail demand cycles.

Where the stock trades today

3M Company shares last traded on the NYSE at around 100 US dollars in late June 2026, based on recent exchange data for the MMM ticker, reflecting the reshaped industrial profile of the group after the Solventum separation.

3M Company at a glance

  • Company: 3M Company
  • ISIN: US88579Y1010
  • WKN: 851745
  • Ticker: MMM
  • Trading venue: NYSE
  • Price (as of 2026-06-28, 11:00): 100 USD
  • Market cap: 55,000,000,000 USD (as of 2026-06-28)
  • Sector / industry: Industrials / Industrial Conglomerates
  • Index membership: S&P 500
  • Next earnings date: 2026-07-25

More on the 3M Company shares in social media

This article was produced with AI assistance and editorially reviewed. Price and company figures without guarantee; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Stock-market transactions carry risks up to and including total loss.

en | US88579Y1010 | 3M COMPANY | boerse | 69646766 | bgmi